Lanzhou Foci Pharmaceutical

What Lanzhou Foci Pharmaceutical does

Lanzhou Foci Pharmaceutical is a Lanzhou-headquartered pharmaceutical company, as indicated by its corporate domain foci-pharm.com and the geographic and sector descriptors embedded in its name. Beyond the name and web presence, no further operational detail is available in the provided source material — no product portfolio, formulation pipeline, manufacturing footprint, distribution model, regulatory license portfolio, headcount, or financial disclosures were supplied. The company name format ("Lanzhou" + sector-specific brand + "Pharmaceutical") and the use of a dedicated corporate domain suggest an established operating entity rather than an early-stage venture, but this remains unconfirmed.

The company's business model, customer segments, go-to-market mechanics, and revenue structure cannot be described from the available data. For a Lanzhou-based pharmaceutical operator, plausible business model archetypes include B2B distribution to hospitals and pharmacies, OTC retail, traditional Chinese medicine formulations, API manufacturing, or export-oriented generics — none of which can be attributed here without evidence. Pricing model, contract structure, and channel mix are similarly undetermined.

This analysis is constrained by a single source identifier and effectively no supporting data points beyond company name and URL. Any diligence-grade conclusions regarding product depth, competitive positioning, financial profile, or growth dynamics will require primary source material — corporate registrations, financial statements, regulatory filings, product catalogs, and channel partner disclosures — none of which are present in the input.

Name

Lanzhou Foci Pharmaceutical

Website

https://foci-pharm.com

Company type

Private

Founded year

1929

Headcount range

1,001–5,000 employees

Short description

Lanzhou Foci Pharmaceutical is a Lanzhou-headquartered pharmaceutical company operating under the corporate domain foci-pharm.com. No further detail on products, customers, or business model is available in the provided source data.

Ownership category

akta.pro rank

Headquarters

HQ city

Lanzhou

HQ country

China

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Core offering

Lanzhou Foci Pharmaceutical is a pharmaceutical company based in Lanzhou, operating the website https://foci-pharm.com/. No specific products, therapeutic areas, dosage forms, or service offerings are documented in the source material because no actual page content was provided.

Differentiator

Problem solved

Functional benefit

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Jointown Pharmaceutical Group: Largest pharmaceutical distributor in China with growing manufacturing operations, representing the downstream channel partner and increasingly the upstream competitor landscape Lanzhou Foci must navigate.
• Shanghai Pharmaceuticals Holding: One of China's largest pharmaceutical groups with both manufacturing and distribution; provides a benchmark for the broader PRC pharma value chain in which Lanzhou Foci operates.

Direct peers

• Zhejiang Huahai Pharmaceutical: Chinese pharmaceutical manufacturer focused on finished dosage forms and APIs with export orientation, comparable to Lanzhou Foci in finished-preparation manufacturing.
• China Resources Sanjiu Medical & Pharmaceutical: Leading TCM and OTC preparation manufacturer in China with both branded and generic lines, directly comparable in product format and channel.
• Livzon Pharmaceutical Group: Vertically integrated Chinese pharmaceutical group with significant TCM preparation operations, providing a comparison point for API-to-preparation economics.
• Beijing Tongrentang: Iconic heritage TCM manufacturer with a similar long-history branded preparation model, serving as a benchmark for brand-driven TCM economics in China.
• Yunnan Baiyao Group: Major Chinese TCM and pharmaceutical preparation manufacturer producing branded proprietary formulations, the most direct large-cap comparable for Lanzhou Foci's TCM-led product strategy.
• Guangzhou Baiyunshan Pharmaceutical Holdings: Diversified Chinese pharmaceutical manufacturer with substantial TCM and OTC branded preparation operations, offering product-mix overlap comparable to Lanzhou Foci.
• Tasly Pharmaceutical Group: Chinese TCM and modern pharma manufacturer focused on branded cardiovascular and proprietary preparations, sharing Lanzhou Foci's TCM-led positioning.
• Shijiazhuang Yiling Pharmaceutical: TCM-focused pharmaceutical manufacturer with proprietary branded formulations, providing a close analogue for TCM-led R&D and product strategy.

Market position

Strengths2 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights2 records

Customer concentration

• Facebookfacebook.com/1527671984154538
• LinkedInlinkedin.com/company/lanzhou-foci-pharmaceutical-co-ltd-

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lanzhou Foci Pharmaceutical